B7-h1 expressed by activated CD8 T cells is essential for their survival.
about
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection.B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating BimRelevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse modelB7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8(+) T cellsInferring the Impact of Regulatory Mechanisms that Underpin CD8+ T Cell Control of B16 Tumor Growth In vivo Using Mechanistic Models and Simulation.The B7 homologues and their receptors in hematologic malignancies.GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells.PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous System.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.PD-L1 serves as a double agent in separating GVL from GVHD.Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes.CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.
P2860
Q35036388-751E9A9E-23FE-4577-8D5A-52C585187C33Q35166971-98212E92-A238-4336-BEB2-92B90F0A75F8Q36109361-F647708E-E4E4-4466-8398-AF4744EA556BQ36388507-64A0BEC4-7B8B-447E-A93A-59376526E327Q36474557-9BA5D4FF-09B2-461E-B49C-0448822AA02BQ37042232-52EC7261-F902-4AA4-8723-4D59231576AEQ37376269-B9F363E3-AFCB-4BD7-AF8E-D0653256274BQ37400079-FFEB5F51-46EE-4D72-8F66-0541FA69A73BQ37554202-2B3E384F-7E55-4D64-B060-6DA50297B202Q37988965-945B4AEB-CE39-4C2F-A7E8-0F12C52A1808Q38782845-9781B285-2EF5-4908-9D6B-AA14317171DCQ41369044-619910BC-0A50-4D8F-ADF4-1BA18EB9717DQ42256164-36C2305B-6A2A-4527-AE37-7F87CD683118Q44323857-A28B3D44-EE48-4797-ABEC-9AF086E9E59DQ47120629-B8BBF41B-879B-4608-BD91-F6D087F17A6AQ47424027-78EF4F94-18D9-4E15-B909-AF5491287D3DQ51054718-C475E5B4-8C81-4BDE-AD6F-B7A35D5E1E05Q51750565-51E48341-DBF2-4789-B38B-049F503E71ABQ52718482-D62C5889-9919-4F5A-8443-7CC9695E8F78
P2860
B7-h1 expressed by activated CD8 T cells is essential for their survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@ast
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@en
type
label
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@ast
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@en
prefLabel
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@ast
B7-h1 expressed by activated CD8 T cells is essential for their survival.
@en
P2093
P2860
P356
P1476
B7-h1 expressed by activated CD8 T cells is essential for their survival
@en
P2093
Christopher J Krco
Eugene D Kwon
Kimberley J Harris
Rachel M Gibbons
Susan M Harrington
Vesna Pulko
P2860
P304
P356
10.4049/JIMMUNOL.1003976
P407
P577
2011-10-24T00:00:00Z